EASL Clinical Practice Guidelines

References

[1]Shah, V.H. Alcoholic liver disease: the buzz may be gone, but the hangover remains. Hepatology. 2009; 51: 14831484
CrossRef | Scopus (3)

[2]Gao, B. and Bataller, R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011; 141: 15721585
Abstract | Full Text | Full Text PDF | PubMed | Scopus (79)

[3]Guyatt, G.H., Oxman, A.D., Kunz, R., Falck-Ytter, Y., Vist, G.E., Liberati, A. et al. Going from evidence to recommendations. Br Med J. 2008; 336: 10491051
CrossRef | PubMed

[4]Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., and Patra, J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009; 373: 22232233
Abstract | Full Text | Full Text PDF | PubMed | Scopus (485)

[5]WHO, European Status Report on Alcohol and Health 2010. Copenhagen: WHO Regional Office for Europe; 2010.

[6]Anderson, H.R. and Baumburg, B. Alcohol in Europe. A public health perspective. Institute of Alcohol Studies, London; 2006

[7]Roulot, D., Costes, J.L., Buyck, J.F., Warzocha, U., Gambier, N., Czernichow, S. et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut. 2010; 60: 977984
CrossRef | PubMed | Scopus (31)

[8]Zatonski, W.A., Sulkowska, U., Manczuk, M., Rehm, J., Boffetta, P., Lowenfels, A.B. et al. Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe. Eur Addict Res. 2010; 16: 193201
CrossRef | PubMed | Scopus (25)

[9]Leon DA, Collier T. Trends in mortality from liver cirrhosis in Europe in EASL meeting on alcoholic liver disease. Athens: 2010.

[10]Leon, D.A. and McCambridge, J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet. 2006; 367: 5256
Abstract | Full Text | Full Text PDF | PubMed | Scopus (186)

[11]Parna, K. and Rahu, K. Dramatic increase in alcoholic liver cirrhosis mortality in Estonia in 19922008. Alcohol Alcohol. 2010; 45: 548551
CrossRef | PubMed | Scopus (10)

[12]Thomson, S.J., Westlake, S., Rahman, T.M., Cowan, M.L., Majeed, A., Maxwell, J.D. et al. Chronic liver disease an increasing problem: a study of hospital admission and mortality rates in England, 19792005, with particular reference to alcoholic liver disease. Alcohol Alcohol. 2008; 43: 416422
CrossRef | PubMed | Scopus (17)

[13]Welch, C., Harrison, D., Short, A., and Rowan, K. The increasing burden of alcoholic liver disease on United Kingdom critical care units: secondary analysis of a high quality clinical database. J Health Serv Res Policy. 2008; 13: 4044
CrossRef | PubMed | Scopus (9)

[14]Bell, G. and Cremona, A. Alcohol and death certification: a survey of current practice and attitudes. Br Med J (Clin Res Ed). 1987; 295: 95
CrossRef | PubMed

[15]Ramstedt, M. Alcohol consumption and liver cirrhosis mortality with and without mention of alcohol the case of Canada. Addiction. 2003; 98: 12671276
CrossRef | PubMed | Scopus (37)

[16]Zakhari, S. and Li, T.K. Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease. Hepatology. 2007; 46: 20322039
CrossRef | PubMed | Scopus (68)

[17]Popova, S., Rehm, J., Patra, J., and Zatonski, W. Comparing alcohol consumption in central and Eastern Europe to other European countries. Alcohol Alcohol. 2007; 42: 465473
CrossRef | PubMed | Scopus (73)

[18]Ramstedt, M. Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries. Addiction. 2001; 96: S19S33
PubMed

[19]Mathurin, P. and Deltenre, P. Effect of binge drinking on the liver: an alarming public health issue?. Gut. 2009; 58: 613617
CrossRef | PubMed | Scopus (30)

[20]Rehm, J., Kanteres, F., and Lachenmeier, D.W. Unrecorded consumption, quality of alcohol and health consequences. Drug Alcohol Rev. 2010; 29: 426436
CrossRef | PubMed | Scopus (26)

[21]Gill, J., Tsang, C., Black, H., and Chick, J. Can part of the health damage linked to alcohol misuse in Scotland be attributable to the type of drink and its low price (by permitting a rapid rate of consumption)? A point of view. Alcohol Alcohol. 2010; 45: 398400
CrossRef | PubMed | Scopus (5)

[22]Lang, K., Vali, M., Szucs, S., Adany, R., and McKee, M. The composition of surrogate and illegal alcohol products in Estonia. Alcohol Alcohol. 2006; 41: 446450
CrossRef | PubMed | Scopus (24)

[23]McKee, M., Suzcs, S., Sarvary, A., Adany, R., Kiryanov, N., Saburova, L. et al. The composition of surrogate alcohols consumed in Russia. Alcohol Clin Exp Res. 2005; 29: 18841888
CrossRef | PubMed | Scopus (66)

[24]Szucs, S., Sarvary, A., McKee, M., and Adany, R. Could the high level of cirrhosis in central and Eastern Europe be due partly to the quality of alcohol consumed? An exploratory investigation. Addiction. 2005; 100: 536542
CrossRef | PubMed | Scopus (43)

[25]Gil, A., Polikina, O., Koroleva, N., McKee, M., Tomkins, S., and Leon, D.A. Availability and characteristics of nonbeverage alcohols sold in 17 Russian cities in 2007. Alcohol Clin Exp Res. 2009; 33: 7985
CrossRef | PubMed | Scopus (25)

[26]Lachenmeier, D.W., Samokhvalov, A.V., Leitz, J., Schoeberl, K., Kuballa, T., Linskiy, I.V. et al. The composition of unrecorded alcohol from eastern Ukraine: is there a toxicological concern beyond ethanol alone?. Food Chem Toxicol. 2010; 48: 28422847
CrossRef | PubMed | Scopus (7)

[27]Corrao, G., Rubbiati, L., Bagnardi, V., Zambon, A., and Poikolainen, K. Alcohol and coronary heart disease: a meta-analysis. Addiction. 2000; 95: 15051523
CrossRef | PubMed | Scopus (430)

[28]Klatsky, A.L. Alcohol and cardiovascular diseases. Expert Rev Cardiovasc Ther. 2009; 7: 499506
CrossRef | PubMed | Scopus (24)

[29]Corrao, G., Bagnardi, V., Zambon, A., and Torchio, P. Meta-analysis of alcohol intake in relation to risk of liver cirrhosis. Alcohol Alcohol. 1998; 33: 381392
CrossRef | PubMed

[30]Rehm, J., Taylor, B., Mohapatra, S., Irving, H., Baliunas, D., Patra, J. et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev. 2010; 29: 437445
CrossRef | PubMed | Scopus (53)

[31]Casswell, S. and Thamarangsi, T. Reducing harm from alcohol: call to action. Lancet. 2009; 373: 22472257
Abstract | Full Text | Full Text PDF | PubMed | Scopus (79)

[32]Anderson, P., Chisholm, D., and Fuhr, D.C. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet. 2009; 373: 22342246
Abstract | Full Text | Full Text PDF | PubMed | Scopus (190)

[33]Miller, W., Heather, N., and Hall, W. Calculating standard drink units: international comparisons. Br J Addict. 1991; 86: 4347
CrossRef | PubMed

[34]Saunders, J.B., Aasland, O.G., Babor, T.F., de la Fuente, J.R., and Grant, M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption. Addiction. 1993; 88: 791804
CrossRef | PubMed

[35]Bush, K., Kivlahan, D.R., McDonell, M.S., Fihn, S.D., and Bradley, K.A. The AUDIT Alcohol Consumption Questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med. 1998; 158: 17891795
CrossRef | PubMed | Scopus (638)

[36]Gual, A., Segura, L., Contel, M., Heather, N., and Colom, J. AUDIT-3 and AUDIT-4: effectiveness of two short forms of the alcohol use disorders identification test. Alcohol Alcohol. 2002; 37: 591596
CrossRef | PubMed

[37]Bourdon, K.H., Rae, D.S., Locke, B.Z., Narrow, W.E., and Regier, D.A. Estimating the prevalence of mental disorders in US. Adults from the Epidemiologic Catchment Area Survey. Public Health Rep. 1992; 107: 663668
PubMed

[38]Grant, B.F., Hasin, D.S., Chou, S.P., Stinson, F.S., and Dawson, D.A. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004; 61: 11071115
CrossRef | PubMed | Scopus (496)

[39]Altamirano, J. and Bataller, R. Cigarette smoking and chronic liver diseases. Gut. 2010; 59: 11591162
CrossRef | PubMed | Scopus (11)

[40]Fiellin, D.A., OConnor, P.G., Holmboe, E.S., and Horwitz, R.I. Risk for delirium tremens in patients with alcohol withdrawal syndrome. Subst Abuse. 2002; 23: 8394
PubMed

[41]Amato, L., Minozzi, S., Vecchi, S., and Davoli, M. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev. 2010; 3: CD005063
PubMed

[42]Mayo-Smith, M.F., Beecher, L.H., Fischer, T.L., Gorelick, D.A., Guillaume, J.L., Hill, A. et al. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med. 2004; 164: 14051412
CrossRef | PubMed | Scopus (144)

[43]McKeon, A., Frye, M.A., and Delanty, N. The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry. 2008; 79: 854862
CrossRef | PubMed | Scopus (58)

[44]Mayo-Smith, M.F. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal; JAMA. 1997; 278: 144151

[45]Bayard, M., McIntyre, J., Hill, K.R., and Woodside, J. Jr. Alcohol withdrawal syndrome. Am J Fam Physician. 2004; 69: 14431450
PubMed

[46]Addolorato, G., Leggio, L., Abenavoli, L., Agabio, R., Caputo, F., Capristo, E. et al. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study versus diazepam. Am J Med. 2006; 119: 1318
Scopus (68)

[47]Leggio, L., Kenna, G., and Swift, R. New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications. Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32: 11061117
CrossRef | PubMed | Scopus (29)

[48]Krampe, H. and Ehrenreich, H. Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Curr Pharm Des. 2010; 16: 20762090
CrossRef | PubMed | Scopus (25)

[49]Forns, X., Caballera, J., Bruguera, M., Salmern, J.M., Vilella, A., Mas, A. et al. Disulfiram-induced hepatitis. Report of four cases and review of the literature. J Hepatol. 1994; 21: 853857
PubMed | Scopus (23)

[50]Anton, R.F. Naltrexone for the management of alcohol dependence. N Engl J Med. 2008; 359: 715721
CrossRef | PubMed | Scopus (36)

[51]Kiefer, F. and Mann, K. Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy. Curr Pharm Des. 2010; 16: 20982102
CrossRef | PubMed | Scopus (15)

[52]Anton, R.F., OMalley, S.S., Ciraulo, D.A., Cisler, R.A., Couper, D., Donovan, D.M. et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006; 295: 20032017
CrossRef | PubMed | Scopus (563)

[53]Garbutt, J.C., Kranzler, H.R., OMalley, S.S., Gastfriend, D.R., Pettinati, H.M., Silverman, B.L. et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005; 293: 16171625
CrossRef | PubMed | Scopus (237)

[54]Rsner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S., and Soyka, M. Acamprosate for alcohol dependence. Cochrane Database Syst Rev. 2010; 9: CD004332
PubMed

[55]Addolorato, G., Leggio, L., Ferrulli, A., Caputo, F., and Gasbarrini, A. The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data. Expert Opin Investig Drugs. 2009; 18: 675686
CrossRef | PubMed | Scopus (19)

[56]Heilig, M. and Egli, M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther. 2006; 111: 855876
CrossRef | PubMed | Scopus (178)

[57]Johnson, B.A., Rosenthal, N., Capece, J.A., Wiegand, F., Mao, L., Beyers, K. et al. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA. 2007; 298: 16411651
CrossRef | PubMed | Scopus (210)

[58]Johnson, B.A., Rosenthal, N., Capece, J.A., Wiegand, F., Mao, L., Beyers, K. et al. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med. 2008; 168: 11881199
CrossRef | PubMed | Scopus (42)

[59]Johnson, B.A. Medication treatment of different types of alcoholism. Am J Psychiatry. 2010; 167: 630639
CrossRef | PubMed | Scopus (54)

[60]Addolorato, G. and Leggio, L. Safety and efficacy of baclofen in the treatment of alcohol dependent patients. Curr Pharm Des. 2010; 16: 21132117
CrossRef | PubMed | Scopus (24)

[61]Addolorato, G., Leggio, L., Ferrulli, A., Cardone, S., Vonghia, L., Mirijello, A. et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet. 2007; 370: 19151922
Abstract | Full Text | Full Text PDF | PubMed | Scopus (152)

[62]University of Sheffield Guidance Title: Prevention and early identification of alcohol use disorders in adults and young people. Final draft of Report 2 to the National Institute for Health & Clinical Excellence. Sheffield: The University of Sheffield, School of Health and Related Research (ScHARR); 2009.

[63]Kaner, E.F., Dickinson, H.O., Beyer, F., Pienaar, E., Schlesinger, C., Campbell, F. et al. The effectiveness of brief alcohol interventions in primary care settings: a systematic review. Drug Alcohol Rev. 2009; 28: 301323
CrossRef | PubMed | Scopus (75)

[64]Vasilaki, E.I., Hosier, S.G., and Cox, W.M. The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review. Alcohol Alcohol. 2006; 41: 328335
CrossRef | PubMed | Scopus (137)

[65]Teli, M.R., Day, C.P., Burt, A.D., Bennett, M.K., and James, O.F. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet. 1995; 346: 987990
Abstract | PubMed

[66]Baraona, E. and Lieber, C.S. Alcohol and lipids. in: M. Galanter (Ed.) The consequences of alcoholism. Plenum Press, New York; 1998: 97134

[67]You, M., Considine, R.V., Leone, T.C., Kelly, D.P., and Crabb, D.W. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology. 2005; 42: 568577
CrossRef | PubMed | Scopus (109)

[68]Nakajima, T., Kamijo, Y., Tanaka, N., Sugiyama, E., Tanaka, E., Kiyosawa, K. et al. Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology. 2004; 40: 972980
CrossRef | PubMed | Scopus (0)

[69]Ji, C., Chan, C., and Kaplowitz, N. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J Hepatol. 2006; 45: 717724
PubMed | Scopus (71)

[70]Chedid, A., Mendenhall, C.L., Gartside, P., French, S.W., Chen, T., and Rabin, L. Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol. 1991; 86: 210216
PubMed

[71]Niemela, O., Juvonen, T., and Parkkila, S. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption. J Clin Invest. 1991; 87: 13671374
CrossRef | PubMed

[72]Theruvathu, J.A., Jaruga, P., Nath, R.G., Dizdaroglu, M., and Brooks, P.J. Polyamines stimulate the formation of mutagenic 1,N2-propanodeoxyguanosine adducts from acetaldehyde. Nucleic Acids Res. 2005; 33: 35133520
CrossRef | PubMed | Scopus (45)

[73]Seitz, H.K. and Stickel, F. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem. 2006; 387: 349360
CrossRef | PubMed | Scopus (74)

[74]Wang, Y., Millonig, G., Nair, J., Patsenker, E., Stickel, F., Mueller, S. et al. Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology. 2009; 50: 453461
CrossRef | PubMed | Scopus (35)

[75]Albano, E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc. 2006; 65: 278290
CrossRef | PubMed | Scopus (179)

[76]Lieber, C.S. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev. 1997; 77: 517544
PubMed

[77]Dupont, I., Lucas, D., Clot, P., Menez, C., and Albano, E. Cytochrome P4502E1 inducibility and hydroxyethyl radical formation among alcoholics. J Hepatol. 1998; 28: 564571
PubMed | Scopus (65)

[78]Seth, D., Gorrell, M.D., Cordoba, S., McCaughan, G.W., and Haber, P.S. Intrahepatic gene expression in human alcoholic hepatitis. J Hepatol. 2006; 45: 306320
PubMed | Scopus (33)

[79]Urbaschek, R., McCuskey, R.S., Rudi, V., Becker, K.P., Stickel, F., Urbaschek, B. et al. Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease. Alcohol Clin Exp Res. 2001; 25: 261268
CrossRef | PubMed

[80]Thurman, R.G. II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol. 1998; 275: G605G611
PubMed

[81]Bardag-Gorce, F., Yuan, Q.X., Li, J., French, B.A., Fang, C., Ingelman-Sundberg, M. et al. The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol. Biochem Biophys Res Commun. 2000; 279: 2329
CrossRef | PubMed | Scopus (65)

[82]Bataller, R. and Brenner, D.A. Liver fibrosis. J Clin Invest. 2005; 115: 209218
CrossRef | PubMed

[83]Cubero, F.J., Urtasun, R., and Nieto, N. Alcohol and liver fibrosis. Semin Liver Dis. 2009; 29: 211221
CrossRef | PubMed | Scopus (21)

[84]Moreno, M. and Bataller, R. Cytokines and renin-angiotensin system signaling in hepatic fibrosis. Clin Liver Dis. 2008; 12: 825852
PubMed | Scopus (33)

[85]Firrincieli, D., Boissan, M., and Chignard, N. Epithelial-mesenchymal transition in the liver. Gastroenterol Clin Biol. 2010; 34: 523528
CrossRef | PubMed | Scopus (7)

[86]Becker, U., Deis, A., Sorensen, T.I., Gronbaek, M., Borch-Johnsen, K., Muller, C.F. et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 1996; 23: 10251029
CrossRef | PubMed

[87]Bellentani, S., Saccoccio, G., Costa, G., Tiribelli, C., Manenti, F., Sodde, M. et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut. 1997; 41: 845850
CrossRef | PubMed

[88]Becker, U., Gronbaek, M., Johansen, D., and Sorensen, T.I. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology. 2002; 35: 868875
CrossRef | PubMed | Scopus (55)

[89]Pelletier, S., Vaucher, E., Aider, R., Martin, S., Perney, P., Balmes, J.L. et al. Wine consumption is not associated with a decreased risk of alcoholic cirrhosis in heavy drinkers. Alcohol Alcohol. 2002; 37: 618621
CrossRef | PubMed

[90]Barrio, E., Tome, S., Rodriguez, I., Gude, F., Sanchez-Leira, J., Perez-Becerra, E. et al. Liver disease in heavy drinkers with and without alcohol withdrawal syndrome. Alcohol Clin Exp Res. 2004; 28: 131136
CrossRef | PubMed | Scopus (22)

[91]Wechsler, H. and Austin, S.B. Binge drinking: the five/four measure. J Stud Alcohol. 1998; 59: 122124
PubMed

[92]Hatton, J., Burton, A., Nash, H., Munn, E., Burgoyne, L., and Sheron, N. Drinking patterns, dependency and life-time drinking history in alcohol-related liver disease. Addiction. 2009; 104: 587592
CrossRef | PubMed | Scopus (16)

[93]Lu, X.L., Luo, J.Y., Tao, M., Gen, Y., Zhao, P., Zhao, H.L. et al. Risk factors for alcoholic liver disease in China. World J Gastroenterol. 2004; 10: 24232426
PubMed

[94]Corrao, G., Lepore, A.R., Torchio, P., Valenti, M., Galatola, G., DAmicis, A. et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease. Eur J Epidemiol. 1994; 10: 657664
CrossRef | PubMed | Scopus (74)

[95]Klatsky, A.L., Morton, C., Udaltsova, N., and Friedman, G.D. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med. 2006; 166: 11901195
CrossRef | PubMed | Scopus (72)

[96]Tanaka, K., Tokunaga, S., Kono, S., Tokudome, S., Akamatsu, T., Moriyama, T. et al. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol. 1998; 27: 438443
CrossRef | PubMed | Scopus (80)

[97]Loft, S., Olesen, K.L., and Dossing, M. Increased susceptibility to liver disease in relation to alcohol consumption in women. Scand J Gastroenterol. 1987; 22: 12511256
CrossRef | PubMed

[98]Norton, R., Batey, R., Dwyer, T., and MacMahon, S. Alcohol consumption and the risk of alcohol related cirrhosis in women. Br Med J (Clin Res Ed). 1987; 295: 8082
CrossRef | PubMed

[99]Pares, A., Caballeria, J., Bruguera, M., Torres, M., and Rodes, J. Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatol. 1986; 2: 3342
PubMed

[100]Sato, N., Lindros, K.O., Baraona, E., Ikejima, K., Mezey, E., Jarvelainen, H.A. et al. Sex difference in alcohol-related organ injury. Alcohol Clin Exp Res. 2001; 25: 40S45S
CrossRef | PubMed

[101]Eagon, P.K. Alcoholic liver injury: influence of gender and hormones. World J Gastroenterol. 2010; 16: 13771384
CrossRef | PubMed | Scopus (16)

[102]Frezza, M., di Padova, C., Pozzato, G., Terpin, M., Baraona, E., and Lieber, C.S. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med. 1990; 322: 9599
CrossRef | PubMed

[103]Mandayam, S., Jamal, M.M., and Morgan, T.R. Epidemiology of alcoholic liver disease. Semin Liver Dis. 2004; 24: 217232
CrossRef | PubMed | Scopus (95)

[104]Stewart, S.H. and Connors, G.J. Ethnicity, alcohol drinking and changes in transaminase activity among heavy drinkers. J Natl Med Assoc. 2007; 99: 564569
PubMed

[105]Wickramasinghe, S.N., Corridan, B., Izaguirre, J., Hasan, R., and Marjot, D.H. Ethnic differences in the biological consequences of alcohol abuse: a comparison between south Asian and European males. Alcohol Alcohol. 1995; 30: 675680
PubMed

[106]Stinson, F.S., Grant, B.F., and Dufour, M.C. The critical dimension of ethnicity in liver cirrhosis mortality statistics. Alcohol Clin Exp Res. 2001; 25: 11811187
CrossRef | PubMed

[107]Naveau, S., Giraud, V., Borotto, E., Aubert, A., Capron, F., and Chaput, J.C. Excess weight risk factor for alcoholic liver disease. Hepatology. 1997; 25: 108111
CrossRef | PubMed

[108]Raynard, B., Balian, A., Fallik, D., Capron, F., Bedossa, P., Chaput, J.C. et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology. 2002; 35: 635638
CrossRef | PubMed | Scopus (155)

[109]Bellentani, S., Pozzato, G., Saccoccio, G., Crovatto, M., Croce, L.S., Mazzoran, L. et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut. 1999; 44: 874880
CrossRef | PubMed

[110]Boccato, S., Pistis, R., Noventa, F., Guido, M., Benvegnu, L., and Alberti, A. Fibrosis progression in initially mild chronic hepatitis C. J Viral Hepat. 2006; 13: 297302
CrossRef | PubMed | Scopus (45)

[111]Pessione, F., Degos, F., Marcellin, P., Duchatelle, V., Njapoum, C., Martinot-Peignoux, M. et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology. 1998; 27: 17171722
CrossRef | PubMed | Scopus (256)

[112]Serfaty, L., Chazouilleres, O., Poujol-Robert, A., Morand-Joubert, L., Dubois, C., Chretien, Y. et al. Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study. Hepatology. 1997; 26: 776779
CrossRef | PubMed

[113]Wiley, T.E., McCarthy, M., Breidi, L., and Layden, T.J. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology. 1998; 28: 805809
CrossRef | PubMed

[114]Harris, D.R., Gonin, R., Alter, H.J., Wright, E.C., Buskell, Z.J., Hollinger, F.B. et al. The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med. 2001; 134: 120124
CrossRef | PubMed

[115]Machado, M.V., Ravasco, P., Martins, A., Almeida, M.R., Camilo, M.E., and Cortez-Pinto, H. Iron homeostasis and H63D mutations in alcoholics with and without liver disease. World J Gastroenterol. 2009; 15: 106111
CrossRef | PubMed | Scopus (8)

[116]Ganne-Carrie, N., Christidis, C., Chastang, C., Ziol, M., Chapel, F., Imbert-Bismut, F. et al. Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow-up study. Gut. 2000; 46: 277282
CrossRef | PubMed | Scopus (55)

[117]Ropero Gradilla, P., Villegas Martinez, A., Fernandez Arquero, M., Garcia-Agundez, J.A., Gonzalez Fernandez, F.A., Benitez Rodriguez, J. et al. C282Y and H63D mutations of HFE gene in patients with advanced alcoholic liver disease. Rev Esp Enferm Dig. 2001; 93: 156163
PubMed

[118]Hrubec, Z. and Omenn, G.S. Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol Clin Exp Res. 1981; 5: 207215
CrossRef | PubMed

[119]Reed, T., Page, W.F., Viken, R.J., and Christian, J.C. Genetic predisposition to organ-specific end points of alcoholism. Alcohol Clin Exp Res. 1996; 20: 15281533
CrossRef | PubMed | Scopus (78)

[120]Zintzaras, E., Stefanidis, I., Santos, M., and Vidal, F. Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease?. Hepatology. 2006; 43: 352361
CrossRef | PubMed | Scopus (101)

[121]Stickel, F. and Osterreicher, C.H. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol. 2006; 41: 209224
CrossRef | PubMed | Scopus (63)

[122]Tian, C., Stokowski, R.P., Kershenobich, D., Ballinger, D.G., and Hinds, D.A. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet. 2010; 42: 2123
CrossRef | PubMed | Scopus (98)

[123]Stickel, F., Buch, S., Lau, K., Meyer zu Schwabedissen, H., Berg, T., Ridinger, M. et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology. 2010; 53: 8695
CrossRef | PubMed | Scopus (54)

[124]MacSween, R.N. and Burt, A.D. Histologic spectrum of alcoholic liver disease. Semin Liver Dis. 1986; 6: 221232
CrossRef | PubMed

[125]Lefkowitch, J.H. Morphology of alcoholic liver disease. Clin Liver Dis. 2005; 9: 3753
PubMed | Scopus (53)

[126]Hall, P.D. Pathological spectrum of alcoholic liver disease. Alcohol Alcohol. 1994; 2: 303313

[127]Edmondson, H.A., Peters, R.L., Frankel, H.H., and Borowsky, S. The early stage of liver injury in the alcoholic. Medicine (Baltimore). 1967; 46: 119129
CrossRef | PubMed

[128]Telli, M.R., Day, C.P., Burt, A.D., Bennett, M.K., and James, O.F. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet. 1995; 346: 987990
CrossRef | PubMed

[129]Galambos, J.T. and Shapira, R. Natural history of alcoholic hepatitis. J Clin Invest. 1973; 52: 29522962
CrossRef | PubMed

[130]Marbet, U.A., Bianchi, L., Meury, U., and Stalder, G.A. Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease. J Hepatol. 1987; 4: 364372
PubMed

[131]Nakano, M., Worner, T.M., and Lieber, C.S. Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression. Gastroenterology. 1982; 83: 777785
PubMed

[132]Worner, T.M. and Lieber, C.S. Perivenular fibrosis as precursor lesion of cirrhosis. JAMA. 1985; 254: 627630
CrossRef | PubMed

[133]Galambos, J.T. Natural history of alcoholic hepatitis. Gastroenterology. 1972; 63: 10261035
PubMed

[134]Sorensen, T.I., Orholm, M., Bentsen, K.D., Hoybye, G., Eghoje, K., and Christoffersen, P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet. 1984; 2: 241244
Abstract | PubMed | Scopus (0)

[135]Mathurin, P., Beuzin, F., Louvet, A., Carrie-Ganne, N., Balian, A., Trinchet, J.C. et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment Pharmacol Ther. 2007; 25: 10471054
CrossRef | PubMed | Scopus (23)

[136]Naveau, S., Gaude, G., Asnacios, A., Agostini, H., Abella, A., Barri-Ova, N. et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology. 2009; 49: 97105
CrossRef | PubMed | Scopus (67)

[137]Bouchier, I.A., Hislop, W.S., and Prescott, R.J. A prospective study of alcoholic liver disease and mortality. J Hepatol. 1992; 16: 290297
PubMed | Scopus (30)

[138]Hock, B., Schwarz, M., Domke, I., Grunert, V.P., Wuertemberger, M., Schiemann, U. et al. Validity of carbohydrate-deficient transferrin (% CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction. 2005; 100: 14771486
CrossRef | PubMed | Scopus (44)

[139]Bell, H., Tallaksen, C.M., Try, K., and Haug, E. Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department. Alcohol Clin Exp Res. 1994; 18: 11031108
CrossRef | PubMed | Scopus (79)

[140]Seitz, H.K. Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase. Am J Clin Nutr. 2006; 83: 12521253
PubMed

[141]Imbert-Bismut, F., Ratziu, V., Pieroni, L., Charlotte, F., Benhamou, Y., and Poynard, T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 2001; 357: 10691075
Abstract | Full Text | Full Text PDF | PubMed | Scopus (887)

[142]Poynard, T., Aubert, A., Bedossa, P., Abella, A., Naveau, S., Paraf, F. et al. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology. 1991; 100: 13971402
PubMed

[143]Puukka, K., Hietala, J., Koivisto, H., Anttila, P., Bloigu, R., and Niemela, O. Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase activity. Am J Clin Nutr. 2006; 83: 13511354 (quiz 1448-1449)
PubMed

[144]Cohen J, A. and Kaplan, M.M. The SGOT/SGPT ratio an indicator of alcoholic liver disease. Dig Dis Sci. 1979; 24: 835838
CrossRef | PubMed

[145]Nalpas, B., Vassault, A., Charpin, S., Lacour, B., and Berthelot, P. Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit. Hepatology. 1986; 6: 608614
CrossRef | PubMed

[146]Nyblom, H., Berggren, U., Balldin, J., and Olsson, R. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol. 2004; 39: 336339
CrossRef | PubMed | Scopus (63)

[147]Lieber, C.S., Weiss, D.G., Morgan, T.R., and Paronetto, F. Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis. Am J Gastroenterol. 2006; 101: 15001508
CrossRef | PubMed | Scopus (32)

[148]Naveau, S., Raynard, B., Ratziu, V., Abella, A., Imbert-Bismut, F., Messous, D. et al. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol. 2005; 3: 167174
PubMed | Scopus (81)

[149]Cales, P., Oberti, F., Michalak, S., Hubert-Fouchard, I., Rousselet, M.C., Konate, A. et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005; 42: 13731381
CrossRef | PubMed | Scopus (255)

[150]Rosenberg, W.M., Voelker, M., Thiel, R., Becka, M., Burt, A., Schuppan, D. et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology. 2004; 127: 17041713
PubMed | Scopus (438)

[151]Parkes, J., Roderick, P., Harris, S., Day, C., Mutimer, D., Collier, J. et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut. 2010; 59: 12451251
CrossRef | PubMed | Scopus (50)

[152]Mueller, S., Millonig, G., Sarovska, L., Friedrich, S., Reimann, F.M., Pritsch, M. et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol. 2010; 16: 966972
CrossRef | PubMed | Scopus (21)

[153]Nahon, P., Kettaneh, A., Tengher-Barna, J., Ziol, M., de Ledinghen, V., Douvin, C. et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol. 2008; 49: 10621068
PubMed | Scopus (66)

[154]Nguyen-Khac, E., Chatelain, D., Tramier, B., Decrombecque, C., Robert, B., Joly, J.P. et al. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther. 2008; 28: 11881198
CrossRef | PubMed | Scopus (56)

[155]Nguyen-Khac, E., Saint-Leger, P., Tramier, B., Coevoet, H., Capron, D., and Dupas, J.L. Noninvasive diagnosis of large esophageal varices by Fibroscan: strong influence of the cirrhosis etiology. Alcohol Clin Exp Res. 2010; 34: 11461153
PubMed

[156]Janssens, F., de Suray, N., Piessevaux, H., Horsmans, Y., de Timary, P., and Starkel, P. Can transient elastography replace liver histology for determination of advanced fibrosis in alcoholic patients: a real-life study. J Clin Gastroenterol. 2010; 44: 575582
PubMed

[157]Foucher, J., Chanteloup, E., Vergniol, J., Castera, L., Le Bail, B., Adhoute, X. et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006; 55: 403408
CrossRef | PubMed | Scopus (500)

[158]Mueller, S. and Sandrin, L. Liver stiffness: a novel parameter for the diagnosis of liver disease. Hepatic Med Evid Res. 2010; 2: 4967
CrossRef

[159]Castera, L. and Pinzani, M. Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango?. Gut. 2010; 59: 861866
CrossRef | PubMed | Scopus (56)

[160]Gelsi, E., Dainese, R., Truchi, R., Marine-Barjoan, E., Anty, R., Autuori, M. et al. Effect of detoxification on liver stiffness assessed by Fibroscan ((R)) in alcoholic patients. Alcohol Clin Exp Res. 2011; 35: 566570
CrossRef | PubMed | Scopus (5)

[161]Zoli, M., Cordiani, M.R., Marchesini, G., Lervese, T., Labate, A.M., Bonazzi, C. et al. Prognostic indicators in compensated cirrhosis. Am J Gastroenterol. 1991; 86: 15081513
PubMed

[162]dAssignies, G., Ruel, M., Khiat, A., Lepanto, L., Chagnon, M., Kauffmann, C. et al. Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods. Eur Radiol. 2009; 19: 20332040
CrossRef | PubMed | Scopus (36)

[163]Mancini, M., Prinster, A., Annuzzi, G., Liuzzi, R., Giacco, R., Medagli, C. et al. Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy. Metabolism. 2009; 58: 17241730
PubMed | Scopus (12)

[164]Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., and Marchesini, G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010; 53: 372384
Abstract | Full Text | Full Text PDF | PubMed | Scopus (146)

[165]Sandahl, T.D., Jepsen, P., Thomsen, K.L., and Vilstrup, H. Incidence and mortality of alcoholic hepatitis in Denmark 19992008: a nationwide population based cohort study. J Hepatol. 2011; 54: 760764
PubMed | Scopus (9)

[166]Kryger, P., Schlichting, P., Dietrichson, O., and Juhl, E. The accuracy of the clinical diagnosis in acute hepatitis and alcoholic liver disease. Clinical versus morphological diagnosis. Scand J Gastroenterol. 1983; 18: 691696
CrossRef | PubMed

[167]Mookerjee, R.P., Lackner, C., Stauber, R., Stadlbauer, V., Deheragoda, M., Aigelsreiter, A. et al. The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis. J Hepatol. 2011; 55: 11031111
PubMed | Scopus (11)

[168]Ramond, M.J., Poynard, T., Rueff, B., Mathurin, P., Theodore, C., Chaput, J.C. et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med. 1992; 326: 507512
CrossRef | PubMed

[169]Katoonizadeh, A., Laleman, W., Verslype, C., Wilmer, A., Maleux, G., Roskams, T. et al. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut. 2011; 59: 15611569
CrossRef | Scopus (37)

[170]Lucey, M., Mathurin, P., and Morgan, T.R. Alcoholic hepatitis. N Engl J Med. 2009; 360: 27582769
CrossRef | PubMed | Scopus (123)

[171]Maddrey, W.C., Boitnott, J.K., Bedine, M.S., Weber, F.L., Mezey, E., and White, R.I. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978; 75: 193199
PubMed

[172]Carithers, R.L. Jr., Herlong, H.F., Diehl, A.M., Shaw, E.W., Combes, B., Fallon, H.J. et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial. Ann Intern Med. 1989; 110: 685690
CrossRef | PubMed

[173]Phillips, M., Curtis, H., Portmann, B., Donaldson, N., Bomford, A., and OGrady, J. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis a randomised clinical trial. J Hepatol. 2006; 44: 784790
PubMed | Scopus (50)

[174]Dominguez, M., Rincon, D., Abraldes, J.G., Miquel, R., Colmenero, J., Bellot, P. et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol. 2008; 103: 27472756
CrossRef | PubMed | Scopus (35)

[175]Dunn, W., Jamil, L.H., Brown, L.S., Wiesner, R.H., Kim, W.R., Menon, K.V.N. et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005; 41: 353358
CrossRef | PubMed | Scopus (131)

[176]Forrest, E.H., Evans, C.D., Stewart, S., Phillips, M., Oo, Y.H., McAvoy, N.C. et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut. 2005; 54: 11741179
CrossRef | PubMed | Scopus (100)

[177]Srikureja, W., Kyulo, N.L., Runyon, B.A., and Hu, K.Q. Meld is a better prognostic model than ChildTurcottePugh score or discriminant function score in patients with alcoholic hepatitis. J Hepatol. 2005; 42: 700706
PubMed | Scopus (87)

[178]Louvet, A., Naveau, S., Abdelnour, M., Ramond, M.J., Diaz, E., Fartoux, L. et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007; 45: 13481354
CrossRef | PubMed | Scopus (91)

[179]Mathurin, P., OGrady, J., Carithers, R.L., Phillips, M., Louvet, A., Mendenhall, C.L. et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011; 60: 255260
CrossRef | PubMed | Scopus (47)

[180]Moreau, R. and Lebrec, D. Acute rena failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology. 2003; 37: 233243
CrossRef | PubMed | Scopus (112)

[181]Louvet, A., Wartel, F., Castel, H., Dharancy, S., Hollebecque, A., Canva-Delcambre, V. et al. Prospective screening of infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology. 2009; 137: 541548
PubMed | Scopus (38)

[182]Imperiale, T.F., OConnor, J., and McCullough, A.J. Corticosteroids are effective in patients with severe alcoholic patients. Am J Gastroenterol. 1999; 94: 30663067
CrossRef | PubMed

[183]Daures, J.P., Peray, P., Bories, P., Blanc, P., Youfsi, A., Michel, H. et al. Place de la corticothrapie dans le traitement des hpatites alcooliques aigus. Rsultats dune mta-analyse. Gastroenterol Clin Biol. 1991; 15: 223228
PubMed

[184]Imperiale, T.F. and McCullough, A.J. Do corticosteroids reduce mortality from alcoholic hepatitis?. Ann Intern Med. 1990; 113: 299307
CrossRef | PubMed

[185]Reynolds, T.B. Corticosteroid therapy of alcoholic hepatitis: how many studies it will take?. Hepatology. 1990; 12: 619621
CrossRef | PubMed

[186]Christensen, E. and Gludd, C. Glucocorticosteroids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut. 1995; 37: 113118
CrossRef | PubMed

[187]Rambaldi, A., Saconato, H.H., Christensen, E., Thordlund, K., Wetterslev, J., and Gluud, C. Systematic review: glucocorticosteroids for alcoholic hepatitis a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther. 2008; 27: 11671178
CrossRef | PubMed | Scopus (52)

[188]Cabre, E., Rodriguez-Iglesias, P., Caballeria, J., Quer, J.C., Sanchez-Lombrana, J.L., Pares, A. et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology. 2000; 32: 3642
CrossRef | PubMed

[189]Mendenhall, C.L., Anderson, S., Garcia-Pont, P., Goldberg, S., Kiernan, T., Seef, L.B. et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med. 1984; 311: 14641470
CrossRef | PubMed

[190]Mathurin, P., Abdelnour, M., Ramond, M.J., Carbonnell, N., Fartoux, L., Serfaty, L. et al. Early change in bilirubin levels (ECBL) is an important prognostic factor in severe biopsy-proven alcoholic hepatitis (AH) treated by prednisolone. Hepatology. 2003; 38: 13631369
CrossRef | PubMed

[191]Louvet, A., Diaz, E., Dharancy, S., Coevoet, H., Texier, F., Thvenot, T. et al. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. J Hepatol. 2008; 48: 465470
PubMed | Scopus (49)

[192]Mathurin, P., Moreno, C., Samuel, D., Dumortier, J., Salleron, J., Durand, F. et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011; 365: 17901800
CrossRef | PubMed | Scopus (51)

[193]Akriviadis, E., Botla, R., Briggs, W., Han, S., Reynolds, T., and Shakil, O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000; 119: 16371648
PubMed

[194]Lebrec, D., Thabut, D., Oberti, F., Perarnau, J.M., Condat, B., Barraud, H. et al. Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology. 2010; 138: 17551762
PubMed | Scopus (32)

[195]Krishna De, B., Gangopadhyay, S., Dutta, D., Baksi, S.D., Pani, A., and Ghosh, P. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial. World J Gastroenterol. 2009; 15: 16131619
CrossRef | PubMed | Scopus (32)

[196]Mathurin, P., Louvet, A., Dao, T., Nahon, P., Diaz, E., Carbonell, N. et al. Addition of pentoxifylline to prednisolone for severe alcoholic hepatitis does not improve 6-month survival: results of the Corpentox trial. Hepatology. 2011; 54: 391A

[197]Spahr, L., Rubbia-Brandt, L., Frossard, J.L., Giostra, E., Rougemont, A.L., Pugin, J. et al. Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized pilot study. J Hepatol. 2002; 37: 448455
PubMed | Scopus (112)

[198]Spahr, L., Rubbia-Brandt, L., Pugin, J., Giostra, E., Frossard, J.L., Borisch, B. et al. Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood. J Hepatol. 2001; 35: 582589
PubMed | Scopus (43)

[199]Naveau, S., Chollet-Martin, S., Dharancy, S., Mathurin, P., Jouet, P., Piquet, M.A. et al. A double blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology. 2004; 39: 13901397
CrossRef | PubMed | Scopus (155)

[200]Boetticher, N.C., Peine, C.J., Kwo, P., Abrams, G.A., Patel, T., Aqel, B. et al. A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology. 2008; 135: 19531960
PubMed | Scopus (89)

[201]Moreno, C., Langlet, P., Hittelet, A., Lasser, L., Degre, D., Evrard, S. et al. Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial. J Hepatol. 2010; 53: 11171122
PubMed | Scopus (13)

[202]Nguyen-Khac, E., Thevenot, T., Piquet, M.A., Benferhat, S., Goria, O., Chatelain, D. et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med. 2011; 365: 17811789
CrossRef | PubMed | Scopus (22)

[203]Cabre, E., Gonzalez-Huix, F., Abdad-Lacruz, A., Esteve, M., Acero, D., Fernades-Banares, F. et al. Effects of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics: a randomized controlled trial. Gastroenterology. 1990; 98: 715720
PubMed

[204]Jalan, R., Sen, S., Steiner, C., Kapoor, D., Alisa, A., and Williams, R. Extracorporeal liver support with molecular absorbents recirculating system in patients with severe alcoholic hepatitis. J Hepatol. 2003; 38: 2431
PubMed | Scopus (106)

[205]Halle, P., Pare, P., Kaptein, K., Kanel, G., Redeker, A.G., and Reynolds, T.B. Double-blind controlled trial of propylthiouracyl in patients with severe acute alcoholic hepatitis. Gastroenterology. 1982; 82: 925931
PubMed

[206]Orrego, H., Blake, J.E., Blendis, L.M., Compton, K.V., and Israel, Y. Long-term treatment of alcoholic liver disease with propylthiouracil. N Engl J Med. 1987; 317: 14211427
CrossRef | PubMed

[207]Orrego, H., Kalant, H., Israel, Y., Blake, J., Medline, A., Rankin, J.G. et al. Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease. Gastroenterogy. 1978; 76: 105115

[208]Akriviadis, E.A., Steindel, H., Pinto, P.C., Fong, T.L., Kanel, G., Reynolds, T.B. et al. Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis. Gastroenterology. 1990; 99: 811818
PubMed

[209]Trinchet, J.C., Beaugrand, M., Callard, P., Hartmann, D.J., Gotheil, C., and Nusgens, B.V. Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial. Gastroenterol Clin Biol. 1989; 13: 551555
PubMed

[210]Saunders, J.B., Walters, J.R.F., Davies, P., and Paton, A. A 20-year prospective study of cirrhosis. BMJ. 1981; 282: 263266
CrossRef | PubMed

[211]Jepsen, P., Ott, P., Andersen, P.K., Srensen, H.T., and Vilstrup, H. The clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010; 51: 16751682
CrossRef | PubMed | Scopus (26)

[212]Fleming, K.M., Aithal, G.P., Card, T.R., and West, J. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther. 2010; 32: 13431350
CrossRef | PubMed | Scopus (7)

[213]Tandon, P. and Garcia-Tsao, G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008; 28: 2642
CrossRef | PubMed | Scopus (112)

[214]NKontchou, G., Paries, J., Htar, M.T.T., Ganne-Carrie, N., Costentin, L., Grando-Lemaire, V. et al. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral c cirrhosis. Clin Gastroenterol Hepatol. 2006; 4: 10621068
PubMed | Scopus (53)

[215]Das, V., Boelle, P.Y., Galbois, A., Guidet, B., Maury, E., Carbonell, N. et al. Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival. Crit Care Med. 2010; 38: 21082116
CrossRef | PubMed | Scopus (37)

[216]Bell, H., Jahnsen, J., Kittang, E., Raknerud, N., and Sandvik, L. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand J Gastroenterol. 2004; 39: 858863
CrossRef | PubMed | Scopus (36)

[217]Pessione, F., Ramond, M.J., Peters, L., Pham, B.N., Batel, P., Rueff, B. et al. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int. 2003; 23: 4553
CrossRef | PubMed

[218]Jepsen, P., Vilstrup, H., Andersen, P.K., Lash, T.L., and Srensen, H.T. Co-morbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study. Hepatology. 2008; 48: 214220
CrossRef | PubMed | Scopus (20)

[219]Stickel, F., Hoehn, B., Schuppan, D., and Seitz, H.K. Review article: nutritional therapy in alcoholic liver disease. Aliment Pharmacol Ther. 2003; 18: 357373
CrossRef | PubMed | Scopus (56)

[220]European Liver Transplant Registry. <http://www.eltr.org>; 2011 [cited 2011 November].
http://www.eltr.org

[221]Neuberger, J. Transplantation for alcoholic liver disease: a perspective from Europe. Liver Transpl Surg. 1998; 4: S51S57
CrossRef | PubMed

[222]US Transplant.org. <http://www.ustransplant.org/default.aspx>; 2011 [cited 2011 November].
http://www.ustransplant.org/default.aspx

[223]Neuberger, J., Adams, D., MacMaster, P., Maidment, A., and Speed, M. Assessing priorities for allocation of donor liver grafts: survey of public and clinicians. BMJ. 1998; 317: 172175
CrossRef | PubMed

[224]Hasin, D., McCloud, S., Li, Q., and Endicott, J. Cross-system agreement among demographic subgroups: DSM-III, DSM-III-R, DSM-IV and ICD-10 diagnoses of alcohol use disorders. Drug Alcohol Depend. 1996; 41: 127135
PubMed | Scopus (48)

[225]Adam, R., McMaster, P., OGrady, J.G., Castaing, D., Klempnauer, J.L., Jamieson, N. et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl. 2003; 9: 12311243
CrossRef | PubMed | Scopus (293)

[226]Burra, P., Mioni, D., Cecchetto, A., Cillo, U., Zanus, G., Fagiuoli, S. et al. Histological features after liver transplantation in alcoholic cirrhotics. J Hepatol. 2001; 34: 716722
PubMed | Scopus (39)

[227]Mackie, J., Groves, K., Hoyle, A., Garcia, C., Garcia, R., Gunson, B. et al. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transpl. 2001; 7: 418427
CrossRef | PubMed | Scopus (69)

[228]Burra, P., Senzolo, M., Adam, R., Delvart, V., Karam, V., Germani, G. et al. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant. 2010; 10: 138148
CrossRef | PubMed | Scopus (46)

[229]Poynard, T., Naveau, S., Doffoel, M., Boudjema, K., Vanlemmens, C., Mantion, G. et al. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group. J Hepatol. 1999; 30: 11301137
PubMed | Scopus (67)

[230]Vanlemmens, C., Di Martino, V., Milan, C., Messner, M., Minello, A., Duvoux, C. et al. Immediate listing for liver transplantation versus standard care for ChildPugh stage B alcoholic cirrhosis: a randomized trial. Ann Intern Med. 2009; 150: 153161
CrossRef | PubMed

[231]Carithers, R.L. Jr., Herlong, H.F., Diehl, A.M., Shaw, E.W., Combes, B., Fallon, H.J. et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med. 1989; 110: 685690
CrossRef | PubMed

[232]Veldt, B.J., Laine, F., Guillygomarch, A., Lauvin, L., Boudjema, K., Messner, M. et al. Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol. 2002; 36: 9398
PubMed | Scopus (58)

[233]Merion, R.M., Schaubel, D.E., Dykstra, D.L., Freeman, R.B., Port, F.K., and Wolfe, R.A. The survival benefit of liver transplantation. Am J Transplant. 2005; 5: 307313
CrossRef | PubMed | Scopus (286)

[234]Lucey, M.R., Schaubel, D.E., Guidinger, M.K., Tome, S., and Merion, R.M. Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit. Hepatology. 2009; 50: 400406
CrossRef | PubMed | Scopus (24)

[235]Kamath, P.S., Wiesner, R.H., Malinchoc, M., Kremers, W., Therneau, T.M., Kosberg, C.L. et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33: 464470
CrossRef | PubMed | Scopus (1566)

[236]Walter, M., Scholler, G., Moyzes, D., Hildebrandt, M., Neuhaus, R., Danzer, G. et al. Psychosocial prediction of abstinence from ethanol in alcoholic recipients following liver transplantation. Transplant Proc. 2002; 34: 12391241
PubMed | Scopus (8)

[237]Burra, P., Smedile, A., Angelico, M., Ascione, A., and Rizzetto, M. Liver transplantation in Italy: current status. Study Group on Liver Transplantation of the Italian Association for the Study of the Liver (A.I.S.F.). Dig Liver Dis. 2000; 32: 249256
PubMed

[238]Gish, R.G., Lee, A.H., Keeffe, E.B., Rome, H., Concepcion, W., and Esquivel, C.O. Liver transplantation for patients with alcoholism and end-stage liver disease. Am J Gastroenterol. 1993; 88: 13371342
PubMed

[239]Pageaux, G.P., Perney, P., and Larrey, D. Liver transplantation for alcoholic liver disease. Addict Biol. 2001; 6: 301308
CrossRef | PubMed | Scopus (13)

[240]Tome, S. and Lucey, M.R. Timing of liver transplantation in alcoholic cirrhosis. J Hepatol. 2003; 39: 302307
PubMed | Scopus (44)

[241]Tome, S., Martinez-Rey, C., Gonzalez-Quintela, A., Gude, F., Brage, A., Otero, E. et al. Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease. J Hepatol. 2002; 36: 793798
PubMed | Scopus (55)

[242]Kenngott, S., Gerbes, A.L., Schauer, R., and Bilzer, M. Rapid development of esophageal squamous cell carcinoma after liver transplantation for alcohol-induced cirrhosis. Transpl Int. 2003; 16: 639641
CrossRef | PubMed | Scopus (21)

[243]Murray, J.F., Dawson, A.M., and Sherlock, S. Circulatory changes in chronic liver disease. Am J Med. 1958; 24: 358367
PubMed

[244]Rayes, N., Bechstein, W.O., Keck, H., Blumhardt, G., Lohmann, R., and Neuhaus, P. Cause of death after liver transplantation: an analysis of 41 cases in 382 patients. Zentralbl Chir. 1995; 120: 435438
PubMed

[245]Sherman, D. and Williams, R. Liver transplantation for alcoholic liver disease. J Hepatol. 1995; 23: 474479
PubMed | Scopus (16)

[246]Tang, H., Boulton, R., Gunson, B., Hubscher, S., and Neuberger, J. Patterns of alcohol consumption after liver transplantation. Gut. 1998; 43: 140145
CrossRef | PubMed

[247]Weinrieb, R.M., Van Horn, D.H., McLellan, A.T., Alterman, A.I., Calarco, J.S., OBrien, C.P. et al. Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed. Psychosomatics. 2001; 42: 110116
PubMed | Scopus (27)

[248]Weinrieb, R.M., Van Horn, D.H., McLellan, A.T., Volpicelli, J.R., Calarco, J.S., and Lucey, M.R. Drinking behavior and motivation for treatment among alcohol-dependent liver transplant candidates. J Addict Dis. 2001; 20: 105119
CrossRef | PubMed

[249]Simo, K.A., Sereika, S., Bitner, N., Newton, K.N., and Gerber, D.A. Medical epidemiology of patients surviving 10 years after liver transplantation. Clin Transplant. 2010; 25: 360367
CrossRef | PubMed | Scopus (2)

[250]Duvoux, C., Delacroix, I., Richardet, J.P., Roudot-Thoraval, F., Metreau, J.M., Fagniez, P.L. et al. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation. 1999; 67: 418421
CrossRef | PubMed

[251]Haagsma, E.B., Hagens, V.E., Schaapveld, M., van den Berg, A.P., de Vries, E.G., Klompmaker, I.J. et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol. 2001; 34: 8491
PubMed | Scopus (170)

[252]Berlakovich, G.A., Langer, F., Freundorfer, E., Windhager, T., Rockenschaub, S., Sporn, E. et al. General compliance after liver transplantation for alcoholic cirrhosis. Transpl Int. 2000; 13: 129135
PubMed

[253]Cowling, T., Jennings, L.W., Goldstein, R.M., Sanchez, E.Q., Chinnakotla, S., Klintmalm, G.B. et al. Societal reintegration after liver transplantation: findings in alcohol-related and non-alcohol-related transplant recipients. Ann Surg. 2004; 239: 9398
CrossRef | PubMed | Scopus (20)

[254]Mathurin, P. and Lucey, M.R. Management of alcoholic hepatitis. J Hepatol. 2012; 56: S39S45
PubMed | Scopus (4)